FDA Re-Org Makes Chief Of Staff Liaison Between Centers And Commissioner
Executive Summary
A newly created FDA Office of the Chief of Staff will serve as the major point of contact between FDA centers and offices, and the Commissioner, according to an Aug. 30 Federal Register notice
You may also be interested in...
FDA Chief Of Staff Barclay Hails From Agency, By Way Of M Street
Lisa Barclay returns to government from Zuckerman Spaeder where she co-authored a report urging more regulation of nutritional supplements based on nanotechnology.
FDA Chief Of Staff Barclay Hails From Agency, By Way Of M Street
Lisa Barclay returns to government from Zuckerman Spaeder where she co-authored a report urging more regulation of nutritional supplements based on nanotechnology.
FDA Reorganization Adds "Directorate" Layer, But Sharpens Agency's Focus
Commissioner Margaret Hamburg’s structural reorganization of FDA leaves the current leadership of the drug and biologic review centers intact but adds a new layer of management and accountability between the medical product center directors and the commissioner’s office.